Adma Biologics: Q4 Earnings Snapshot

Associated Press
Updated 1 min read
0
In this article:

RAMSEY, N.J. (AP) _ Adma Biologics Inc. (ADMA) on Thursday reported a loss of $19.4 million in its fourth quarter.

On a per-share basis, the Ramsey, New Jersey-based company said it had a loss of 20 cents.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.

The infectious disease drug developer posted revenue of $14 million in the period.

For the year, the company reported that its loss widened to $75.7 million, or 88 cents per share. Revenue was reported as $42.2 million.

In the final minutes of trading on Thursday, the company's shares hit $2.05. A year ago, they were trading at $2.98.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMA at https://www.zacks.com/ap/ADMA

Advertisement

Recommended Stories